Abstract:Objective: Cervical cancer is one of the most common gynecological malignancies. The interaction between tumor microenvironment and immune infiltration is closely related to the progression of cervical squamous cell carcinoma (CSCC) and patients’ prognosis. Herein, a panel of immune-related genes was established for more accurate prognostic prediction.Methods: The transcriptome information of tumor and normal samples were obtained from TCGA-CSCC and GTEx. Differentially expressed genes (DEGs) were defined from it. Immune-related genes (IRGs) were retrieved from the ImmPort database. After removing the transcriptome data which not mentioned in GSE44001, IR-DEGs were preliminarily identified. Then, TCGA-CSCC samples were divided into training and testing set (3:1) randomly. Univariate Cox analysis, LASSO regression analysis and multivariate Cox analysis were used in turn to construct the signature to predict the overall survival (OS) and disease-free survival (DFS). External validation was performed in GSE44001, and initial clinical validation was performed by qRT-PCR. Function enrichment analysis, immune infiltration analysis and establishment of nomogram were conducted as well.Results: A prognostic prediction signature consisting of seven IR-DEGs was established. High expression of NRP1, IGF2R, SERPINA3, TNF and low expression of ICOS, DES, HCK suggested that CSCC patients had shorter OS (POS<0.001) and DFS (PDFS<0.001). AUC values of 1-, 3-, five- year OS were 0.800, 0.831 and 0.809. Analyses in other validation sets showed good consistency with the results in training set. The signature can serve as an independent prognostic factor for OS (HR = 1.166, p < 0.001). AUC values of 1-, 3-, five- year OS based on the nomogram were 0.769, 0.820 and 0.807. Functional enrichment analysis suggested that these IR-DEGs were associated with receptor interaction and immune cell activity. Immune infiltration analysis indicated that patients in high-risk group had lower immune infiltration, weaker immune function, and were more likely to benefit from immune checkpoint inhibitor therapy. Through qRT-PCR on clinical samples, expression of NRP1, IGF2R, SERPINA3 and TNF were significantly upregulated in tumor tissue, while ICOS and DES were significantly downregulated.Conclusion: To conclude, the immune-related signature can provide strong support for exploration of immune infiltration, prediction of prognosis and response to immunotherapy through stratify CSCC patients into subgroups.

Development of a Novel Immune Infiltration-Based Gene Signature to Predict Prognosis and Immunotherapy Response of Patients With Cervical Cancer

Identification and Experimental Validation of Immune-Associate Lncrnas for Predicting Prognosis in Cervical Cancer

Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer

Immune Infiltration Characteristics and a Gene Prognostic Signature Associated With the Immune Infiltration in Head and Neck Squamous Cell Carcinoma

Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer

Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer

The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer.

A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma

Identification of a tumor microenvironment-related gene signature to improve the prediction of cervical cancer prognosis

Identification of Immune-Related Gene Signature Model for Predicting Lung Cancer Survival and Response to Immunotherapy

A Panel of Seven Immune-Related Genes Can Serve As a Good Predictive Biomarker for Cervical Squamous Cell Carcinoma

A Novel Comprehensive Immune-Related Gene Signature As a Promising Survival Predictor for the Patients with Head and Neck Squamous Cell Carcinoma.

Development of an Immune-Related Prognostic Signature in Breast Cancer

Identification of An Immune Signature Predicting Prognosis Risk of Patients in Gastric Cancer

Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors.

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer

Prognostic Implications of Immune-Related Genes’ (irgs) Signature Models in Cervical Cancer and Endometrial Cancer

An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer

A Tumor-Infiltration Cd8+T Cell-Based Gene Signature For Facilitating The Prognosis And Estimation Of Immunization Responses In Hpv Plus Head And Neck Squamous Cell Cancer

An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.

Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer